Multiwave Technologies AG
Multiwave Technologies AG is a Swiss company founded in 2015 that specializes in advanced medical imaging technologies, particularly in metamaterials and artificial intelligence. The company has developed innovative products such as the MGNTQ™ portable MRI device and the WearMe™ wireless metamaterial blanket, aimed at improving patient care and accessibility in medical imaging.
Company Overview
Multiwave Technologies AG is a privately held company founded in March 2015, headquartered in Plan-les-Ouates, Geneva, Switzerland. The company focuses on revolutionizing medical imaging through advanced technologies, particularly in the field of metamaterials and artificial intelligence. With a small team of 15 employees, Multiwave Technologies aims to develop innovative solutions that enhance medical imaging capabilities.
Products and Innovations
Multiwave Technologies AG has developed several key products, including the MGNTQ™, a portable MRI device that utilizes metamaterial technologies and AI software. This device is designed for use in various medical settings, including intensive care and emergency situations. The MGNTQ™ is notable for its mobility, affordability, and low acoustic levels, making it suitable for sensitive patients. Additionally, the company has introduced WearMe™, an ultra-thin, flexible, and wireless metamaterial blanket aimed at reducing scan cycle times.
Specialties and Technologies
The company specializes in several areas, including metamaterials, medical imaging, artificial intelligence, smart retail, MRI technology, and electromagnetism. Multiwave Technologies AG's innovations in metamaterials contribute to advancements in medical imaging, particularly in portable and low-field MRI applications. Their focus on deep science technology positions them at the forefront of medical equipment manufacturing.
Research and Collaborations
Multiwave Technologies AG has engaged in various research initiatives and collaborations. The company signed a 4-year industrial Chair for medical imaging with the A*Midex Foundation of Aix-Marseille University and a master research agreement with the University of Sussex for ultra-low field MRI research. The development of 7TNS MRI Pads was funded by the EU through the H2020 FET innovation Launchpad call, highlighting the company's commitment to advancing medical imaging technologies.
Market Impact and Accessibility
The MGNTQ™ portable MRI device is designed to be accessible in various settings, including rural areas and medical deserts, as it can be transported easily and does not require specialized infrastructure. Its affordability, being 5-10 times less expensive than conventional MRI scanners, enhances its potential market impact. The device's design allows for use outside traditional hospital environments, making advanced medical imaging more accessible to diverse patient populations.